Literature DB >> 6486249

Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the Veterans Administration-Penn study.

G E Woody, A T McLellan, L Luborsky, C P O'Brien, J Blaine, S Fox, I Herman, A T Beck.   

Abstract

One hundred ten nonpsychotic opiate addicts were randomly assigned to receive paraprofessional drug counseling alone, counseling plus cognitive-behavioral psychotherapy, or counseling plus supportive-expressive psychotherapy. Patients were classified low-severity, mid-severity, or high-severity on the basis of the number and severity of their psychiatric symptoms. Overall, the addition of professional psychotherapy was associated with greater benefits than was drug counseling alone. Low-severity patients made considerable and approximately equal progress with added psychotherapy or with counseling alone. Mid-severity patients had better outcomes with additional psychotherapy than with counseling alone, but counseling did effect numerous significant improvements. High-severity patients made little progress with counseling alone, but with added psychotherapy made considerable progress and used both prescribed and illicit drugs less often.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6486249     DOI: 10.1176/ajp.141.10.1172

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  18 in total

Review 1.  Co-occurring disorders in substance abuse treatment: issues and prospects.

Authors:  Patrick M Flynn; Barry S Brown
Journal:  J Subst Abuse Treat       Date:  2007-06-15

2.  The effectiveness of psychodynamic psychotherapies: An update.

Authors:  Peter Fonagy
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

3.  Service use and barriers to care among heroin users: results from a national survey.

Authors:  Orion Mowbray; Brian E Perron; Amy S B Bohnert; Amy R Krentzman; Michael G Vaughn
Journal:  Am J Drug Alcohol Abuse       Date:  2010-08-02       Impact factor: 3.829

4.  Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence.

Authors:  Roger D Weiss; Margaret L Griffin; David E Marcovitz; Blake T Hilton; Garrett M Fitzmaurice; R Kathryn McHugh; Kathleen M Carroll
Journal:  J Clin Psychiatry       Date:  2019-03-26       Impact factor: 4.384

5.  The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders.

Authors:  Elizabeth C Saunders; Mark P McGovern; Chantal Lambert-Harris; Andrea Meier; Bethany McLeman; Haiyi Xie
Journal:  Am J Addict       Date:  2015-09-21

6.  Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder.

Authors:  Margaret L Griffin; Dorian R Dodd; Jennifer S Potter; Lindsay S Rice; William Dickinson; Steven Sparenborg; Roger D Weiss
Journal:  Am J Drug Alcohol Abuse       Date:  2013-11-12       Impact factor: 3.829

Review 7.  Inpatient vs outpatient treatment for substance dependence revisited.

Authors:  H M Pettinati; K Meyers; J M Jensen; F Kaplan; B D Evans
Journal:  Psychiatr Q       Date:  1993

Review 8.  Alcoholism and drug abuse in patients with PTSD.

Authors:  L Kofoed; M J Friedman; R Peck
Journal:  Psychiatr Q       Date:  1993

Review 9.  The bipolar patient with comorbid substance use disorder: recognition and management.

Authors:  Mark J Albanese; Ronald Pies
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Variation in GABRA2 predicts drinking behavior in project MATCH subjects.

Authors:  Lance O Bauer; Jonathan Covault; Ofer Harel; Sourish Das; Joel Gelernter; Raymond Anton; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2007-11       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.